Journal Article Summary
The article investigates the use patterns, facilitators, and barriers to accessing ulipristal acetate, a prescription-only emergency contraception, in British Columbia, Canada. Since its introduction in 2015, ulipristal acetate has been recognized as a more effective option compared to the over-the-counter levonorgestrel. Understanding the factors influencing its uptake is crucial, as it can help improve access to effective emergency contraception, particularly for individuals who may benefit from its use, such as those with higher body mass index (BMI).
The study employed a mixed-methods approach, combining quantitative data from prescription records and sales figures with qualitative insights from interviews with patients, pharmacists, and prescribers. Over a three-year period, only 318 patients filled prescriptions for ulipristal acetate, while levonorgestrel was used significantly more, indicating low awareness and uptake of ulipristal acetate. Interviews revealed key barriers to access, including a lack of knowledge about ulipristal acetate, feelings of shame and stigma associated with needing emergency contraception, and various health system obstacles like prescription requirements and costs.
Limitations of the study include the inability to capture inpatient prescriptions and the reliance on sales data as a proxy for actual use. The findings highlight the need for improved education for both healthcare providers and patients about emergency contraception options. Readers are encouraged to discuss any concerns or questions about emergency contraception with their healthcare professionals to ensure they have the most accurate information and support for their reproductive health needs.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Chan Michelle C., Munro Sarah, Schummers Laura, Albert Arianne, Mackenzie Frannie, Soon Judith A., Ragsdale Parkash, Fitzsimmons Brian, et al.. Dispensing and practice use patterns, facilitators and barriers for uptake of ulipristal acetate emergency contraception in British Columbia: a mixed-methods study. CMAJ Open 2021. DOI: 10.9778/cmajo.20200193. PMID: 34848550. PMCID: PMC8648349.
Featured Pill Pals Product
My Way (Levonorgestrel) 1.5 mg Tablet - Generic For Plan B and Morning After Pill --- Lupin Pharma
My Way (Levonorgestrel) 1.5 mg Tablet - Generic For Plan B and Morning After Pill is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. No prescription required for eligible over-the-counter purchases.
